发明授权
- 专利标题： USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY
- 专利标题（中）： 采用神经胎儿细胞系移植治疗
-
申请号： EP94912975.3申请日： 1994-04-11
-
公开(公告)号： EP0696205B1公开(公告)日： 2002-01-23
- 发明人: MAJOR, Eugene O. , TORNATORE, Carlo S. , BANKIEWICZ, Kris
- 申请人： GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS
- 申请人地址： National Institute of Health, 6003 Executive Blvd., Room 309P Rockville, MD 20852 US
- 专利权人： GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS
- 当前专利权人： GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS
- 当前专利权人地址： National Institute of Health, 6003 Executive Blvd., Room 309P Rockville, MD 20852 US
- 代理机构： Smart, Peter John
- 优先权： US46527 19930413
- 国际公布： WO9423754 19941027
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; A61K35/54
摘要：
Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
信息查询
